发明授权
- 专利标题： Insulin resistance improving agent
- 专利标题（中）： 胰岛素抵抗改善剂
-
申请号： US12440807申请日： 2007-09-19
-
公开(公告)号： US08097635B2公开(公告)日： 2012-01-17
- 发明人: Mika Sumi , Fumiko Ogino , Toshikazu Kamiya , Masahiko Nakano , Kazutoshi Kikkawa
- 申请人： Mika Sumi , Fumiko Ogino , Toshikazu Kamiya , Masahiko Nakano , Kazutoshi Kikkawa
- 申请人地址： JP Tokyo JP Tokyo
- 专利权人： Kyowa Hakko Bio Co., Ltd.,Mitsubishi Gas Chemical Company, Inc.
- 当前专利权人： Kyowa Hakko Bio Co., Ltd.,Mitsubishi Gas Chemical Company, Inc.
- 当前专利权人地址： JP Tokyo JP Tokyo
- 代理机构： Fitzpatrick, Cella, Harper & Scinto
- 优先权： JP2006-253265 20060919
- 国际申请： PCT/JP2007/068114 WO 20070919
- 国际公布： WO2008/035686 WO 20080327
- 主分类号： A61K31/44
- IPC分类号： A61K31/44
摘要：
An object of the present invention is to provide a safe and highly effective insulin resistance improving agent or therapeutic agent for type II diabetes. According to the present invention, an insulin resistance improving agent or a therapeutic agent for type II diabetes comprising a compound represented by general formula (I) (wherein R1, R2, and R3 are the same as or different from each other, and each represents lower alkyl, lower alkenyl, lower alkynyl, aralkyl, araryl, phenyl, or a hydrogen atom) or a salt thereof as an active ingredient can be provided.
公开/授权文献
- US20100093780A1 INSULIN RESISTANCE IMPROVING AGENT 公开/授权日：2010-04-15
信息查询
